Posted in | News | Business

NETZSCH-Gerätebau GmbH Acquires GABO QUALIMETER Testanlagen GmbH

On July 9, 2015 NETZSCH-Gerätebau GmbH announced its acquisition of GABO QUALIMETER Testanlagen GmbH.

GABO QUALIMETER Testanlagen GmbH, located in Ahlden, Germany, is a globally leading manufacturer of high-force dynamic mechanical thermal analyzers (DMA/DMTA). Their instruments are the industry standard in the field of tire and rubber testing.

In combination with GABO’s broad range of sample holders and accessories, their instruments are perfectly tailored to the needs of the rapidly growing composites market. Furthermore, the company’s high-temperature DMA (up to 1500°C) is unique worldwide. GABO DMA systems are used daily in the world’s largest and most prestigious companies, academic institutions, and governmental laboratories.

Ronald Gaddum, Managing Director of GABO QUALIMETER Testanlagen GmbH, is clearly satisfied: “The global presence of the NETZSCH Group with its outstanding Sales and Service locations in our main markets, together with GABO’s product spectrum, build a solid foundation for mutually growing the business and taking the lead in the market. GABO’s high-force DMA/DMTA instruments and fully automatic DMAs with automatic sample feed will be making an important contribution in this regard. Through synergistic effects in development, applications and sales, we expect this union to create a market leader offering complete solutions in dynamic mechanical materials testing and thermal analysis.

Our team is excited to collaborate with a globally active, German-based company that understands not only our position but also the possibilities ahead.”

NETZSCH offers a wide range of instruments for rubber characterization, including DSC, TGA and EGA instruments. In the composites field, NETZSCH analytical instruments cover the entire production process, including cure monitoring with DEA. Furthermore, NETZSCH is the technological leader for high-temperature applications in thermal analysis thanks to techniques like STA and DIL.

This acquisition will allow both NETZSCH and GABO customers to benefit from additional product lines, top-level technology in dynamic mechanical testing and a world-wide support structure.

Dr. Thomas Denner, Head of the NETZSCH Analyzing & Testing Business Unit, and Dr. Jürgen Blumm, Managing Director of Marketing & Sales, commented on the acquisition: “We are very excited about the union of NETZSCH and GABO – both are family-owned companies with long traditions and have product lines in leading positions worldwide. This undertaking will enable us to offer an even broader product range to many sectors, especially rubber & tire, composites and high-temperature materials – and all from a single source.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    NETZSCH-Gerätebau GmbH. (2019, February 08). NETZSCH-Gerätebau GmbH Acquires GABO QUALIMETER Testanlagen GmbH. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=44544.

  • MLA

    NETZSCH-Gerätebau GmbH. "NETZSCH-Gerätebau GmbH Acquires GABO QUALIMETER Testanlagen GmbH". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=44544>.

  • Chicago

    NETZSCH-Gerätebau GmbH. "NETZSCH-Gerätebau GmbH Acquires GABO QUALIMETER Testanlagen GmbH". AZoM. https://www.azom.com/news.aspx?newsID=44544. (accessed November 21, 2024).

  • Harvard

    NETZSCH-Gerätebau GmbH. 2019. NETZSCH-Gerätebau GmbH Acquires GABO QUALIMETER Testanlagen GmbH. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=44544.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.